A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to identify the recommended phase 2 regimen(s) RP2R(s) of pasritamig and combination regimens in Part 1 (dose escalation) and to determine safety at the putative RP2R(s) of pasritamig with the combination regimens in Part 2 (dose expansion).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni z zaawansowanym, opornym na leczenie hormonalne rakiem prostaty.
- •Rak prostaty potwierdzony badaniami histologicznymi.
- •Wybrane grupy pacjentów mogą mieć hormono-wrażliwego raka prostaty.
- •Rak, który można zmierzyć lub ocenić pod kątem postępu.
- •Pacjenci, którzy wcześniej przeszli określone terapie (np. leki hormonalne, chemioterapię).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 6, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (15)
Florida Cancer Specialists
Sarasota, United States
Start Midwest
Grand Rapids, United States
Washington University School Of Medicine
St Louis, United States
Perlmutter Cancer Center at NYU Langone Brooklyn
Brooklyn, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island
Mineola, United States
NYU Langone Health
New York, United States
Sidney Kimmel Cancer Center - Jefferson Health
Philadelphia, United States
Icon Cancer Centre Kurralta Park
Kurralta Park, Australia
Macquarie University
Macquarie University, Australia
Peter MacCallum Cancer Centre
Melbourne, Australia
Princess Alexandra Hospital
Woolloongabba, Australia
Hosp Univ Vall D Hebron
Barcelona, Spain
Hosp Univ Fund Jimenez Diaz
Madrid, Spain
Hosp. Univ. 12 de Octubre
Madrid, Spain
Hosp Univ Hm Sanchinarro
Madrid, Spain
Trial contact
Study Contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.